{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:08:33Z","timestamp":1782263313332,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Flemish Research Council","doi-asserted-by":"publisher","award":["12R2119N"],"award-info":[{"award-number":["12R2119N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.xphs.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:07:45Z","timestamp":1568718465000},"page":"3842-3847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example Ibuprofen"],"prefix":"10.1016","volume":"108","author":[{"given":"Rodrigo","family":"Cristofoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Hens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikunjkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valvanera Vozmediano","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.14227\/DT200213P48","article-title":"Survey results for in\u00a0vitro-in\u00a0vivo correlations (IVIVC): critical variables for success","volume":"20","author":"Fotaki","year":"2013","journal-title":"Dissolut Tech"},{"key":"10.1016\/j.xphs.2019.09.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.02.029","article-title":"A\u00a0survey on IVIVC\/IVIVR development in the pharmaceutical industry\u2014past experience and current perspectives","volume":"102","author":"Nguyen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2019.09.012_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.12.010","article-title":"In\u00a0vitro models for the prediction of in\u00a0vivo performance of oral dosage forms: recent progress from partnership through the IMI OrBiTo collaboration","volume":"136","author":"Butler","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.012_bib4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/acs.molpharmaceut.6b00824","article-title":"In\u00a0vivo predictive dissolution (IPD) and biopharmaceutical modeling and simulation: future use of modern approaches and methodologies in a regulatory context","volume":"14","author":"Lennern\u00e4s","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12248-019-0292-3","article-title":"PBPK absorption modeling: establishing the in\u00a0vitro-in\u00a0vivo link-industry perspective","volume":"21","author":"Stillhart","year":"2019","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1208\/s12248-016-9930-1","article-title":"Examining the use of a mechanistic model to generate an in\u00a0vivo\/in\u00a0vitro correlation: journey through a thought process","volume":"18","author":"Mistry","year":"2016","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1208\/s12248-017-0060-1","article-title":"Characterising drug release from immediate-release formulations of a poorly soluble compound, basmisanil, through absorption modelling and dissolution testing","volume":"19","author":"Stillhart","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1021\/acs.molpharmaceut.7b00406","article-title":"Model-based analysis of biopharmaceutic experiments to improve mechanistic oral absorption modeling: an integrated in\u00a0vitro in\u00a0vivo extrapolation perspective using ketoconazole as a model drug","volume":"14","author":"Pathak","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.xphs.2019.09.012_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2016.12.017","article-title":"Prediction of ketoconazole absorption using an updated in\u00a0vitro transfer model coupled to physiologically based pharmacokinetic modelling","volume":"100","author":"Ruff","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/acs.molpharmaceut.7b00396","article-title":"In silico modeling approach for the evaluation of gastrointestinal dissolution, supersaturation, and precipitation of posaconazole","volume":"14","author":"Hens","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.xphs.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from miniscale dissolution test","volume":"23","author":"Takano","year":"2006","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2019.09.012_bib12","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1021\/acs.molpharmaceut.6b00497","article-title":"Justification of drug product dissolution rate and drug substance particle size specifications based on absorption PBPK modeling for lesinurad immediate release tablets","volume":"13","author":"Pepin","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.xphs.2019.09.012_bib13","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jps.20444","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen","volume":"94","author":"Potthast","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpb.2016.03.024","article-title":"Matching phosphate and maleate buffer systems for dissolution of weak acids: equivalence in terms of buffer capacity of bulk solution or surface pH?","volume":"103","author":"Cristofoletti","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.xphs.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1023\/A:1015970502993","article-title":"Dissolution of ionizable drugs in buffered and unbuffered solutions","volume":"5","author":"Ozturk","year":"1988","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.09.012_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2008.07.002","article-title":"Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development","volume":"363","author":"Sugano","year":"2008","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.xphs.2016.08.024","article-title":"Bridging the gap between in\u00a0vitro dissolution and the time course of ibuprofen-mediating pain relief","volume":"105","author":"Cristofoletti","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40268-014-0070-8","article-title":"Ibuprofen sodium is absorbed faster than standard ibuprofen tablets: results of two open-label, randomized, crossover pharmacokinetic studies","volume":"14","author":"Legg","year":"2014","journal-title":"Drugs R D"},{"issue":"10","key":"10.1016\/j.xphs.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.xphs.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jps.2600520629","article-title":"Percent absorbed time plots derived from blood level and\/or urinary excretion data","volume":"52","author":"Wagner","year":"1963","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2019.09.012_bib21","series-title":"Applied biopharmaceutics and pharmacokinetics","first-page":"177","article-title":"Pharmacokinetics of oral absorption","author":"Duan","year":"2016"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2006.05.010","article-title":"Influence of granulation and compaction on the particle size of ibuprofen--development of a size analysis method","volume":"321","author":"Le","year":"2006","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.09.012_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2008.06.023","article-title":"Effect of particle properties on the flowability of ibuprofen powders","volume":"362","author":"Liu","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2019.09.012_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/2210289201102010088","article-title":"Preparation and characterization of ibuprofen nanoparticles by using solvent\/antisolvent precipitation","volume":"2","author":"Mansouri","year":"2011","journal-title":"Open Conf Proc J"},{"key":"10.1016\/j.xphs.2019.09.012_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-0248(02)01523-3","article-title":"Influence of crystal habit on the compression and densification mechanism of ibuprofen","volume":"243","author":"Di Martino","year":"2002","journal-title":"J\u00a0Cryst Growth"},{"key":"10.1016\/j.xphs.2019.09.012_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ppsc.19890060127","article-title":"Determination of effective surface area for the chemical reaction of fine particulate materials","volume":"6","author":"Senna","year":"1989","journal-title":"Part Part Syst Char"},{"issue":"2","key":"10.1016\/j.xphs.2019.09.012_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1208\/s12248-019-0298-x","article-title":"Dissolution and translational modeling strategies toward establishing an in\u00a0vitro-in\u00a0vivo link-a workshop summary report","volume":"21","author":"Heimbach","year":"2019","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2019.09.012_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2019.01.010","article-title":"A\u00a0novel technique for intraduodenal administration of drug suspensions\/solutions with concurrent pH monitoring applied to ibuprofen formulations","volume":"136","author":"Hofmann","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"10.1016\/j.xphs.2019.09.012_bib29","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/acs.molpharmaceut.7b00425","article-title":"In\u00a0vivo dissolution and systemic absorption of immediate release ibuprofen in human gastrointestinal tract under fed and fasted conditions","volume":"14","author":"Koenigsknecht","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2019.09.012_bib30","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/acs.molpharmaceut.7b00426","article-title":"Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in\u00a0vivo dissolution and absorption of ionizable drugs","volume":"14","author":"Hens","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.xphs.2019.09.012_bib31","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/cpt.1364","article-title":"Innovation for generic drugs: science and research under the generic drug user fee amendments of 2012","volume":"105","author":"Lionberger","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2019.09.012_bib32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jcph.929","article-title":"Decision science for generic drug development and review","volume":"59","author":"Lionberger","year":"2019","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:29:43Z","timestamp":1758360583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919305854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0022354919305854"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.09.012","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example Ibuprofen","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}